Juan Sebastian Saldivar MD, FACMG

Dr. Juan-Sebastian Saldivar, M.D., FACMG has been the Chief Medical Officer of AltheaDx, Inc. since November 2014. Dr. Saldivar served as Laboratory Director of Existence Genetics, LLC and Sequenom Center for Molecular Medicine, LLC. Prior to joining AltheaDx, Dr. Saldivar served as Vice President of Clinical Services and Medical Affairs at Sequenom Laboratories, a provider of noninvasive prenatal testing services and wholly owned subsidiary of Sequenom, Inc. From July 2003 to March 2012, Dr. Saldivar filled various roles including Director of Molecular Diagnostics at City of Hope National Medical Center, a National Cancer Institute, while also teaching as a Clinical Associate Professor in the Department of Pathology from January 2010 to March 2012. Dr. Saldivar also served as Director of Clinical Laboratory Services at Perlegen Sciences, Inc., a biotechnology company, from February 2009 to November 2009. Dr. Saldivar serves as a Diplomat of both the American Board of Pathology (ABP) in Molecular Genetic Pathology and the American Board of Medical Genetics (ABMG) in Clinical Molecular Genetics. He is a Doctor at Harvard/Partners Center for Human Genetics and Genomics in Boston (HPCGG). Dr. Saldivar completed fellowships in Medical Genetics and Clinical Molecular Genetics. He has published extensively in the field of molecular genetics on the association between genetic variants and disease. He is a Fellow of the American College of Medical Genetics (ACMG) and a Member of both the Association for Molecular Pathology (AMP) and the American Society of Human Genetics (ASHG). Dr. Saldivar received his MD from the University of Texas Southwestern Medical School and his B.A. from Boston University.